(lp0
S'Biotech Quick Pick: Insys Therapeutics Seeking Alpha - Mar 13, 2017 To determine if Insys Therapeutics is a long or short opportunity we will first translate the current stock price into a series of assumptions the market seems to be making about the future of the company. As evidenced by a 98% decline from highs ...Insys Therapeutics Inc  Set to Announce Earnings on Thursday - Chaffey Breeze'
p1
aS'Insys Therapeutics Announces Delay in the Release of its Fourth Quarter and ... GlobeNewswire  - 13 hours ago PHOENIX, March 15, 2017  -- Insys Therapeutics, Inc.   today announced that the Company will delay the release of its financial results for the fourth quarter and full year 2016.Insys Therapeutics, Inc.  Files An 8-K Results of Operations and ... - Market ExclusiveINSYS Therapeutics, Inc.  investors have generally bought the stock ... - Post Analyst'
p2
aS'Insys Therapeutics, Inc. to Present at 2017 RBC Capital Markets Global ... GlobeNewswire  - Feb 14, 2017 PHOENIX, Feb. 14, 2017  -- Insys Therapeutics, Inc.   today announced that Santosh Vetticaden, MD, PhD, Interim Chief Executive Officer, and Chief Medical Officer, and Darryl Baker, Chief&nbsp;...'
p3
aS"Insys Therapeutics Inc  Might Be A Discount At Current Prices Insider Financial - Feb 22, 2017 Throughout December last year, Insys Therapeutics Inc  flat lined around $9 a share. Despite continued effort by management to maintain a positive news flow, and in turn, to buoy positive sentiment, the company couldn't break the $10 a&nbsp;...Insys Therapeutics Inc.  Plunges 5.04% on February 23 - Equities.comEarnings Guidance on Insys Therapeutics, Inc. - Energy Index"
p4
aS'Insys Therapeutics, Inc. to Present at JP Morgan 35th Annual Healthcare Conference GlobeNewswire  - Jan 4, 2017 PHOENIX, Jan. 04, 2017  -- Insys Therapeutics, Inc.   today announced that Santosh Vetticaden, MD, PhD, Senior Vice President and Chief Medical Officer, and Darryl Baker, Chief Financial&nbsp;...Hot Biotech Stocks To Watch Right Now: INSYS Therapeutics , Nivalis ... - The Independent Republic'
p5
aS'Insys Therapeutics to Report Fourth Quarter and Full Year 2016 Results Yahoo Finance - Mar 2, 2017 PHOENIX, March 02, 2017  -- Insys Therapeutics, Inc.   today announced that the Company will release its financial results for the fourth quarter and full year 2016 on Thursday, March 16, 2017, before the&nbsp;...Price Target Analysis: INSYS Therapeutics, Inc.  - News Oracle'
p6
aS'Ignore Trump; Insys Will Stabilize Seeking Alpha - Jan 11, 2017 Predicting where a stock will go is more art than science. Like rolling dice, it is impossible to win 100% of the time. But it sure feels great to be right, especially on record and especially when the rally comes quickly.'
p7
aS'Insys Therapeutics Inc.  Plunges 6.02% on February 24 Equities.com - Feb 24, 2017 Insys Therapeutics Inc.  had a rough trading day for Friday February 24 as shares tumbled 6.02%, or a loss of $-0.77 per share, to close at $12.03.'
p8
aS"INSYS Therapeutics  is in Overbought Territory: What's Next? Yahoo Finance - Feb 24, 2017 If this wasn't enough, INSYS Therapeutics also has a Zacks Rank #4 which puts it into unfortunate company among its peers."
p9
aS'Insys Therapeutics Inc.  Moves Lower on Volume Spike for February 16 Equities.com - Feb 16, 2017 Insys Therapeutics Inc.  traded on unusually high volume on Feb. 16, as the stock lost 0.74% to close at $10.74. On the day, Insys Therapeutics Inc. saw 1.78 million shares trade hands on 9,679 trades. Considering that the stock averages only a ...INSYS Therapeutics, Inc.  has Predicted Move on the 7th day with ... - FactsReporter'
p10
a.